Video: John Butler on Genzyme’s patient-focused approach to #RareDisease

John Butler on Genzyme's approach to rare disease John Butler, President of Personalized Genetic Health at Genzyme, presented at last year's World Orphan Drug Congress USA on the topic ‘Genzyme's patient-focused approach in the rare disease sector.'

Do you want to learn more about:

  • Patient-centered drug development – the key to orphan drug success
  • Successful development through collaboration
  • Building sustainable healthcare systems
  • Win-win-win solutions:  for whom and how?

If so, you need to check out the video below:

For more information on orphan drugs and rare diseases, check out the World Orphan Drug Congress USA. Remember, the earlier you book, the more you save, so register now to secure your seat!

Leave a Reply

Your email address will not be published. Required fields are marked *